Company: ARMP
Filing Date: 2025-08-13
Form Type: S-3
Source: 0001104659-25-077648
Chunk: 23

Company: Armata Pharmaceuticals, Inc.
Filing Date: 2025-08-13
Form: S-3
Chunk 23
---
laws and the applicable provisions of the Washington
Business Corporation Act (“WBCA”). This information is qualified entirely by reference to the applicable provisions of our
articles of incorporation, bylaws and the WBCA. For information on how to obtain copies of our articles of incorporation and bylaws, which
are exhibits to the registration statement of which this prospectus is a part, see “Where You Can Find More Information” and
“Incorporation of Certain Information by Reference.”

Common Stock

Voting

Our common stock is entitled
to one vote for each share held on all matters submitted to a vote of the shareholders, including the election of directors, except for
matters that are voted on exclusively by a separate class or series of our shareholders and not by the holders of common stock, and does
not have cumulative voting rights. Accordingly, the holders of a majority of the shares of our common stock entitled to vote in any election
of directors can elect all of the directors standing for election.

Dividends

Subject to preferences that
may be applicable to any then-outstanding preferred stock, the holders of common stock are entitled to receive dividends, if any, as may
be declared from time to time by our board of directors out of legally available funds.

Liquidation

In the event of our liquidation,
dissolution or winding-up, holders of our common stock will be entitled to share ratably in the net assets legally available for distribution
to shareholders after the payment of all our debts and other liabilities, subject to the satisfaction of any liquidation preference granted
to the holders of any outstanding shares of preferred stock.

Rightsand Preferences

Holders of our common stock
have no preemptive, conversion or subscription rights, and there is no redemption or sinking fund provisions applicable to our common
stock. The rights, preferences and privileges of the holders of our common stock are subject to, and may be adversely affected by, the
rights of the holders of shares of any series of our preferred stock that are outstanding or that we may designate and issue in the future.

Fully Paid and Nonassessable

All of our outstanding shares
of common stock are, and the shares of common stock to be issued in any offering under this prospectus will be, fully paid and nonassessable.

Preferred Stock

Our board of directors has
the authority, without further action by the shareholders, to issue up to 10,000,000 shares of preferred stock in one or more series,
to establish from time to